Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EPS (Weighted Average and Diluted) (2016 - 2025)

INVO Fertility has reported EPS (Weighted Average and Diluted) over the past 15 years, most recently at -$0.77 for Q3 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 94.9% to -$0.77 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $7.44 through Sep 2025, up 106.98% year-over-year, with the annual reading at -$30.19 for FY2024, 55.19% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$0.77 for Q3 2025 at INVO Fertility, up from -$7.95 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $28.69 in Q4 2024 and troughed at -$61.61 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$4.1 (2023), against an average of -$6.38.
  • Year-over-year, EPS (Weighted Average and Diluted) tumbled 15266.67% in 2022 and then soared 146.57% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.03 in 2021, then tumbled by 15266.67% to -$4.55 in 2022, then plummeted by 1254.07% to -$61.61 in 2023, then surged by 146.57% to $28.69 in 2024, then tumbled by 102.68% to -$0.77 in 2025.
  • Per Business Quant, the three most recent readings for IVF's EPS (Weighted Average and Diluted) are -$0.77 (Q3 2025), -$7.95 (Q2 2025), and -$12.53 (Q1 2025).